{"id":140470,"date":"2024-12-10T16:18:06","date_gmt":"2024-12-10T10:48:06","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=140470"},"modified":"2024-12-10T16:18:09","modified_gmt":"2024-12-10T10:48:09","slug":"why-are-shares-of-divis-lab-neuland-lab-and-other-pharma-cdmo-stock-falling","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/why-are-shares-of-divis-lab-neuland-lab-and-other-pharma-cdmo-stock-falling\/","title":{"rendered":"Why are shares of Divi&#8217;s Lab, Neuland Lab, and other Pharma CDMO stock falling?\u00a0"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-2769259226\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>The recent softness in the US Biosecure Act is poised to impact several Indian companies, particularly the pharmaceutical and biotechnology sectors. As the Act aims to limit US partnerships with specific Chinese biotech firms, Indian companies like Divi&#8217;s Labs, Neuland Labs, and Piramal Pharma stand to gain from increased business opportunities. However, uncertainties surrounding the Act&#8217;s implementation may lead to volatility in stock prices. While the legislation presents a chance for Indian firms to expand their market share. The potential delays raise concerns about challenges in competition in the US Market from Chinese Pharma companies.&nbsp;<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-905801343\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><p><strong>Listed below are some of the stocks in focus on softening the US Biosecure Act affecting Indian Pharma CDMO stocks.&nbsp;<\/strong><\/p><p><strong><a href=\"https:\/\/portal.tradebrains.in\/stocks\/DIVISLAB\" target=\"_blank\" rel=\"noreferrer noopener\">Divi\u2019s Laboratories\u00a0<\/a><\/strong><\/p><p>Divi&#8217;s Laboratories is headquartered in Hyderabad. It is a leading Indian pharmaceutical company specializing in the production of Active Pharmaceutical Ingredients (APIs), intermediates, and nutraceutical ingredients. They operate two manufacturing facilities and serve over 100 countries, focusing on generic APIs and custom synthesis for global innovator firms.&nbsp;<\/p><div class=\"trade-content_5\" id=\"trade-1089698450\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><p>With a market capitalization of Rs. 1,57,342 Crores, the shares of Divi\u2019s Laboratories Limited closed at Rs. 5,938.80 per equity share, down 0.35 percent from its previous day\u2019s close price of Rs. 5,959.75.&nbsp;<\/p><p>Its Revenue from operations grew by 22.50 percent from Rs. 1,995 Crores in Q2FY24 to Rs. 2,444 Crores in Q2FY25, accompanied by profits of Rs. 348 Crores to Rs. 510 Crores.&nbsp;<\/p><p><strong><a href=\"https:\/\/portal.tradebrains.in\/stocks\/NEULANDLAB\" target=\"_blank\" rel=\"noreferrer noopener\">Neuland Laboratories\u00a0<\/a><\/strong><\/p><p>Neuland Laboratories was founded in 1984 and is based in Hyderabad. They specialize in manufacturing Active Pharmaceutical Ingredients (APIs) and providing end-to-end chemistry solutions for the pharmaceutical industry. The company operates two FDA-inspected facilities, serving clients in over 85 countries.&nbsp;<\/p><p>With a market capitalization of Rs. 21,616 Crores, the shares of Neuland Laboratories Limited closed at Rs. 16,848 per equity share, down 1.16 percent from its previous day\u2019s close price of Rs. 17,046.20.&nbsp;<\/p><p>Its Revenue from operations declined by 25 percent from Rs. 420.8 Crores in Q2FY24 to Rs. 315.17 Crores in Q2FY25, accompanied by profits of Rs. 89.25 Crores to Rs. 32.84 Crores.<\/p><div class=\"trade-content-10\" id=\"trade-1644844238\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_3_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"2969612066\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><p><strong><a href=\"https:\/\/portal.tradebrains.in\/stocks\/SYNGENE\" target=\"_blank\" rel=\"noreferrer noopener\">Syngene International\u00a0<\/a><\/strong><\/p><p>Syngene International is a leading integrated contract research, development, and manufacturing organization based in Bangalore, India. The company was established in 1993 and provides comprehensive scientific services, including drug discovery, development, and commercial manufacturing, primarily for the pharmaceutical and biotechnology sectors.&nbsp;<\/p><p>With a market capitalization of Rs. 35,588.29 Crores, the shares of Syngene International Limited closed at Rs. 884.10 per equity share, up 1.92 percent from its previous day\u2019s close price of Rs. 867.45.&nbsp;<\/p><p>Its Revenue from operations declined by 2.6 percent from Rs. 931.7 Crores in Q2FY24 to Rs. 907.5 Crores in Q2FY25, accompanied by a profit of Rs. 116.5 Crores to Rs. 106.10 Crores.&nbsp;<\/p><p><strong><a href=\"https:\/\/portal.tradebrains.in\/stocks\/PPLPHARMA\" target=\"_blank\" rel=\"noreferrer noopener\">Piramal Pharma\u00a0<\/a><\/strong><\/p><p>Piramal Pharma which is a part of the Piramal Group and specializes in integrated pharmaceutical solutions, offering services across the drug lifecycle. Their business model includes Piramal Pharma Solutions, a Contract Development and Manufacturing Organization (CDMO), and Piramal Critical Care, focusing on hospital generics.&nbsp;<\/p><p>With a market capitalization of Rs. 34,270.59 Crores, the shares of Piramal Pharma Limited closed at Rs. 258.50 per equity share, up 1.08 percent from its previous day\u2019s close price of Rs. 255.75.&nbsp;<\/p><p>Its Revenue from operations increased by 17.45 percent from Rs. 1,960.57 Crores in Q2FY24 to Rs. 2,302.86 Crores in Q2FY25, accompanied by a profit of Rs. 5.02 Crores to Rs. 22.59 Crores.&nbsp;<\/p><p><strong><a href=\"https:\/\/portal.tradebrains.in\/stocks\/LAURUSLABS\" target=\"_blank\" rel=\"noreferrer noopener\">Laurus Labs\u00a0<\/a><\/strong><\/p><p>Laurus Labs was founded in 2005 and is headquartered in Hyderabad. They are a leading pharmaceutical company specializing in Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDFs).&nbsp;<\/p><p>With a market capitalization of Rs. 30,737.47 Crores, the shares of Laurus Labs Limited closed at Rs. 570.10 per equity share, down 0.35 percent from its previous day\u2019s close price of Rs. 572.10.&nbsp;<\/p><p>Its Revenue from operations increased by 0.16 percent from Rs. 1,226.23 Crores in Q2FY24 to Rs. 1,228.30 Crores in Q2FY25, accompanied by a profit of Rs. 36.95 Crores to Rs. 19.84 Crores.&nbsp;<\/p><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Written by Santhosh S<\/strong><\/p><\/blockquote><h2 class=\"wp-block-heading\" id=\"h-disclaimer\"><strong>Disclaimer<\/strong><\/h2><div class=\"wp-block-image\"><figure class=\"aligncenter\"><img decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/warning-disclaimer-300x300.png\" alt=\"\" class=\"wp-image-26306\"\/><\/figure><\/div><p><strong>The views and investment tips expressed by investment experts\/broking houses\/rating agencies on&nbsp;<a href=\"https:\/\/tradebrains.in\/\">tradebrains.in<\/a>&nbsp;are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing<\/strong>.<\/p><div class=\"trade-after-content\" id=\"trade-3899217564\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>The recent softness in the US Biosecure Act is poised to impact several Indian companies, particularly the pharmaceutical and biotechnology sectors. As the Act aims to limit US partnerships with specific Chinese biotech firms, Indian companies like Divi&#8217;s Labs, Neuland Labs, and Piramal Pharma stand to gain from increased business opportunities. However, uncertainties surrounding the [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":119108,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[31,1789],"tags":[25302,23977,17778,5027,948,936,25303],"class_list":["post-140470","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-trending-news","tag-divis-laboratories-3","tag-laurus-labs","tag-neuland-laboratories","tag-piramal-pharma","tag-stock-market","tag-stock-market-news","tag-syngene-international"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Why are shares of Divi&#039;s Lab, Neuland Lab, and other Pharma CDMO stock falling?\u00a0 - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"The recent softness in the US Biosecure Act is poised to impact several Indian companies, particularly the pharmaceutical and biotechnology sectors. As the Act aims to limit US partnerships with specific Chinese biotech firms, Indian companies like Divi&#039;s Labs, Neuland Labs, and Piramal Pharma stand to gain from increased business opportunities.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/why-are-shares-of-divis-lab-neuland-lab-and-other-pharma-cdmo-stock-falling\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Why are shares of Divi&#039;s Lab, Neuland Lab, and other Pharma CDMO stock falling?\u00a0\" \/>\n<meta property=\"og:description\" content=\"The recent softness in the US Biosecure Act is poised to impact several Indian companies, particularly the pharmaceutical and biotechnology sectors. As the Act aims to limit US partnerships with specific Chinese biotech firms, Indian companies like Divi&#039;s Labs, Neuland Labs, and Piramal Pharma stand to gain from increased business opportunities.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/why-are-shares-of-divis-lab-neuland-lab-and-other-pharma-cdmo-stock-falling\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-10T10:48:06+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-12-10T10:48:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/02\/MARKET0003.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/why-are-shares-of-divis-lab-neuland-lab-and-other-pharma-cdmo-stock-falling\/\",\"url\":\"https:\/\/tradebrains.in\/features\/why-are-shares-of-divis-lab-neuland-lab-and-other-pharma-cdmo-stock-falling\/\",\"name\":\"Why are shares of Divi's Lab, Neuland Lab, and other Pharma CDMO stock falling?\u00a0 - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/why-are-shares-of-divis-lab-neuland-lab-and-other-pharma-cdmo-stock-falling\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/why-are-shares-of-divis-lab-neuland-lab-and-other-pharma-cdmo-stock-falling\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/02\/MARKET0003.jpg\",\"datePublished\":\"2024-12-10T10:48:06+00:00\",\"dateModified\":\"2024-12-10T10:48:09+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"The recent softness in the US Biosecure Act is poised to impact several Indian companies, particularly the pharmaceutical and biotechnology sectors. As the Act aims to limit US partnerships with specific Chinese biotech firms, Indian companies like Divi's Labs, Neuland Labs, and Piramal Pharma stand to gain from increased business opportunities.\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/why-are-shares-of-divis-lab-neuland-lab-and-other-pharma-cdmo-stock-falling\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/why-are-shares-of-divis-lab-neuland-lab-and-other-pharma-cdmo-stock-falling\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/why-are-shares-of-divis-lab-neuland-lab-and-other-pharma-cdmo-stock-falling\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/02\/MARKET0003.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/02\/MARKET0003.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/why-are-shares-of-divis-lab-neuland-lab-and-other-pharma-cdmo-stock-falling\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Why are shares of Divi&#8217;s Lab, Neuland Lab, and other Pharma CDMO stock falling?\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Why are shares of Divi's Lab, Neuland Lab, and other Pharma CDMO stock falling?\u00a0 - Trade Brains Features","description":"The recent softness in the US Biosecure Act is poised to impact several Indian companies, particularly the pharmaceutical and biotechnology sectors. As the Act aims to limit US partnerships with specific Chinese biotech firms, Indian companies like Divi's Labs, Neuland Labs, and Piramal Pharma stand to gain from increased business opportunities.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/why-are-shares-of-divis-lab-neuland-lab-and-other-pharma-cdmo-stock-falling\/","og_locale":"en_US","og_type":"article","og_title":"Why are shares of Divi's Lab, Neuland Lab, and other Pharma CDMO stock falling?\u00a0","og_description":"The recent softness in the US Biosecure Act is poised to impact several Indian companies, particularly the pharmaceutical and biotechnology sectors. As the Act aims to limit US partnerships with specific Chinese biotech firms, Indian companies like Divi's Labs, Neuland Labs, and Piramal Pharma stand to gain from increased business opportunities.","og_url":"https:\/\/tradebrains.in\/features\/why-are-shares-of-divis-lab-neuland-lab-and-other-pharma-cdmo-stock-falling\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2024-12-10T10:48:06+00:00","article_modified_time":"2024-12-10T10:48:09+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/02\/MARKET0003.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/why-are-shares-of-divis-lab-neuland-lab-and-other-pharma-cdmo-stock-falling\/","url":"https:\/\/tradebrains.in\/features\/why-are-shares-of-divis-lab-neuland-lab-and-other-pharma-cdmo-stock-falling\/","name":"Why are shares of Divi's Lab, Neuland Lab, and other Pharma CDMO stock falling?\u00a0 - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/why-are-shares-of-divis-lab-neuland-lab-and-other-pharma-cdmo-stock-falling\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/why-are-shares-of-divis-lab-neuland-lab-and-other-pharma-cdmo-stock-falling\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/02\/MARKET0003.jpg","datePublished":"2024-12-10T10:48:06+00:00","dateModified":"2024-12-10T10:48:09+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"The recent softness in the US Biosecure Act is poised to impact several Indian companies, particularly the pharmaceutical and biotechnology sectors. As the Act aims to limit US partnerships with specific Chinese biotech firms, Indian companies like Divi's Labs, Neuland Labs, and Piramal Pharma stand to gain from increased business opportunities.","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/why-are-shares-of-divis-lab-neuland-lab-and-other-pharma-cdmo-stock-falling\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/why-are-shares-of-divis-lab-neuland-lab-and-other-pharma-cdmo-stock-falling\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/why-are-shares-of-divis-lab-neuland-lab-and-other-pharma-cdmo-stock-falling\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/02\/MARKET0003.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/02\/MARKET0003.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/why-are-shares-of-divis-lab-neuland-lab-and-other-pharma-cdmo-stock-falling\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Why are shares of Divi&#8217;s Lab, Neuland Lab, and other Pharma CDMO stock falling?\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/140470","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=140470"}],"version-history":[{"count":1,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/140470\/revisions"}],"predecessor-version":[{"id":140471,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/140470\/revisions\/140471"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/119108"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=140470"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=140470"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=140470"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}